9 Meters Biopharma, Inc.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
9 Meters Biopharma, Inc. (Nasdaq: NMTR) is a rare and unmet needs focused GI company. The Company is advancing drug candidates for short bowel syndrome and celiac disease. 9 Meters is led by a strong management team with a history of bringing novel therapeutics to market, and the Company owns all global rights to their products, which are backed by more than 150 patents worldwide.
Ticker:
NMTR
Exchange:
Nasdaq
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
North Carolina
Company HQ Country:
United States
Year Founded:
2020
Main Therapeutic Focus:
Lead Product in Development:
Proprietary long-acting GLP-1 agonist for short bowel syndrome and Larazotide for Celiac Disease
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4
Speaker
photo
President & CEO
9 Meters Biopharma, Inc.